Headache and Migraine

The chair of the American Migraine Foundation spoke about the insight gleaned from a recent survey the foundation conducted assessing links between mental health and migraine care. [WATCH TIME: 4 minutes]

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 19, 2022.

Dr Williams discusses best practices for taking care of patients with migraine in a collaborative manner.

A migraine specialist cautions against going through migraine treatments quickly and not utilizing their full potential.

Dr Kita Williams shares her strategy for management of AEs with migraine treatments.

Identified implications of the endocannabinoid system in migraine physiology suggest that this pathway might hold therapeutic potential for some headache disorders.

Here's some of what is coming soon to NeurologyLive® this week.

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is multiple sclerosis.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 12, 2022.

Kita Williams, MD, shares her excitement on the availability of CGRP antagonists in treatment of acute migraine and for prevention of migraines.

Kita Williams, MD, discusses how goals may differ for patients seeking to prevent migraines from occurring vs acute migraine treatment.

Lawrence Newman, MD, offered his insight into the findings of a survey conducted by the American Headache Foundation that identified correlations between migraine and mental health conditions.

Here's some of what is coming soon to NeurologyLive® this week.

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromyelitis optica spectrum disorder.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 5, 2022.

A migraine specialist discusses monitoring of patients with acute migraine.

Dr Williams talks about the role NP/PA play in treating patients with migraines.

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

Although 57% and 50% of patients with migraine reported being diagnosed with an anxiety or depressive disorders, respectively, healthcare professional estimated these conditions occurred in just 29% and 30% of patients, respectively.

Here's some of what is coming soon to NeurologyLive® this week.

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of the Alzheimer's Association.

The study, expected to begin enrollment in May 2023, will evaluate whether cognitive behavioral therapy delivered by telehealth reduces headache days and disability from migraine compared with CBT plus a preventive medication.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 29, 2022.

Dr Williams discusses the role of shared decision-making in treating patients with migraines.

A migraine specialist discusses nonpharmacological treatment options and their use for migraines.